Harmony Biosciences预告2026年第二季度创纪录营收,重申全年业绩指引,并宣布首席财务官更替

美股速递
Jul 16

Harmony Biosciences Holdings, Inc. 发布了2026年第二季度的初步业绩预告,宣布其季度营收将创下历史新高。公司同时重申了其针对2026年全年的营收指引,显示出对实现既定财务目标的信心。

此外,该公司还宣布了其首席财务官(CFO)的职位变动。这一系列声明旨在向市场传达公司强劲的运营表现和稳定的管理层过渡计划。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10